Rosalind Advisors, Inc.

CIK 0001622627 · Q2 2026

13F Equity AUM

$269.2M

+8.2% QoQ

Positions

-1 QoQ

AUM Rank

#5,347

Top 61%

Skill Alpha (FF)

+2.5%/yr^ns

No Clear Edge

Rank #1,193 · Top 14%

vs S&P -0.1%/yr (unadj.)

Quarters Tracked

~2 years

Portfolio Concentration

Top 5: 49.6%Top 10: 74.0%Top 20: 94.1%

DCTH15.4%

FRX12.7%

XERS8.6%

YB4P7.3%

VSTM5.7%

XFOR5.6%

EYPT5.3%

HELP4.8%

VOR4.4%

PCVX4.3%

Others (25)26.0%

HHI (Herfindahl-Hirschman Index) measures portfolio concentration. Low (<1500) = diversified, Moderate (1500-2500), High (>2500) = concentrated bets.

Sector Allocation

Healthcare97.0%

Unclassified3.0%

Portfolio weight by GICS sector based on latest 13F filing. Sectors below 2% are grouped as “Other.”

Position Sizing

Positions: 35Median: 1.11%Avg: 2.86%

0–0.5%

11(2.4%)

0.5–1%

3(2.5%)

1–3%

10(17.0%)

3–5%

4(17.6%)

5%+

7(60.5%)

Count of positions per weight bucket — (%) = combined portfolio weight

Loading summary cards...

Portfolio Overlap

Shared: 0Unique: 35vs 20 funds

0%Low

Fund positions

Consensus CUSIPs

Jaccard similarity of this fund’s portfolio vs the consensus of top 20 funds by AUM. Low (<15%) = contrarian, Moderate (15-40%), High (>40%) = follows the crowd.

Loading overlap analysis...

Position Changes This Quarter

New9Increased7Decreased11Exited12

New Positions

ABVX1.0%

+21K

SELLAS LIFE SCIENCES…0.9%

+569K

SPRB0.4%

+20K

PEPG0.2%

+350K

CGON0.1%

+31K

EYEPOINT PHARMACEUTI…0.1%

+50K

ISHARES TR0.0%

+500K

SPDR SERIES TRUST0.0%

+141K

TENAX THERAPEUTICS I…0.0%

+6K

Increased

VSTM5.7%

+1.8M(+86%)

TLPH2.0%

+1.8M(+54%)

RGNT0.9%

+450K(+179%)

HELP4.8%

+425K(+28%)

FRX12.7%

+280K(+10%)

NRXS1.1%

+222K(+78%)

BFRI0.5%

+112K(+10%)

Decreased

XERS8.6%

-322,719(-10%)

OKUR0.3%

-293,763(-66%)

MYO1.4%

-209,386(-5%)

PYPD0.7%

-208,471(-35%)

BCRX2.7%

-201,553(-22%)

TCE22.8%

-130,000(-39%)

AVIR1.9%

-101,305(-9%)

PCVX4.3%

-90,000(-31%)

VOR4.4%

-51,400(-7%)

EYPT5.3%

-48,507(-5%)

Exited

-100,000

-250,401

-1,275,600

-125,000

-221,616

-200,000

-75,000

INVESCO QQQ TR

-250,000

SPDR S&P 500 ETF…

-125,000

VIRIDIAN THERAPEUTIC…

-263,600

Quarter-over-quarter changes compared to prior 13F filing. New = first appearance; Exited = no longer held.

Loading position changes...

Holdings

Loading holdings...